Nobivac ® Empowers You - Merck Animal Health USA
WEBFULL SIZE PROTECTION, HALF SIZE VACCINES. Choose the best protection for your clients with convenient small dose options for dogs of all sizes.
NOBIVAC® Canine 1-DAPPv - Merck Animal Health USA
WEBNOBIVAC ® CANINE 1-DAPPv provides protection against: Canine Distemper Virus, Canine Adenovirus type 1, Canine Adenovirus type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses). Protects against …
Nobivac® NXT | Merck Animal Health USA
WEBDeliver an unparalleled combination of optimal safety and robust efficacy. Nobivac ® NXT-level RNA particle technology enhances the body’s natural processes to stimulate comprehensive immunity. Adjuvant-free, preservative-free, low-volume, 0.5-mL dose. Total peace of mind for pet owners and you.
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine …
WEBJun 25, 2024 · NOBIVAC NXT Canine Flu H3N2 is the first and only canine influenza vaccine built on Merck Animal Health’s RNA-particle technology platform to deliver optimized protection against the most prevalent canine …
USDA Approves NOBIVAC® NXT Canine Flu H3N2 Vaccine - Merck …
WEBJun 25, 2024 · NOBIVAC NXT Canine Flu H3N2 is the first and only canine influenza vaccine built on Merck Animal Health’s RNA-particle technology platform to deliver optimized protection against the most prevalent canine …
Merck Animal Health Announces Expansion of NOBIVAC® NXT …
WEB20 hours ago · NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health’s RNA-particle technology platform and is designed to deliver optimized protection.
Merck Animal Health Announces Expansion of NOBIVAC® NXT …
WEB1 day ago · NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health’s RNA-particle technology platform and is designed to deliver optimized protection. The same technology was used for NOBIVAC NXT Rabies that launched in Canada in June 2024 and NOBIVAC NXT Canine Flu H3N2 that launched in the U.S. in June 2024.
Nobivac® NXT Rabies - Merck Animal Health Canada
WEBTo help protect cats & dogs, and those who care about them, we’re breaking new ground with Nobivac® NXT Canine-3 Rabies and Nobivac® NXT Feline-3 Rabies, the first and only companion animal rabies vaccines built on RNA particle technology.
Merck Announces Expansion Of Nobivac NXT Platform For
WEB18 hours ago · Notably, the same RNA-particle technology was used for Nobivac NXT Rabies and Nobivac NXT Canine Flu H3N2, both launched in June 2024. Currently, Merck's stock is trading at $115.87, up 0.26 ...
MSD Animal Health's Ground-breaking FeLV Vaccine
WEB1 day ago · RAHWAY, N.J., September 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly USDA-approved NOBIVAC ® NXT vaccine platform to include a best in class solution to protect cats against one of the most common feline …